Tauriga Sciences Inc (TAUG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | N/A | 6 | N/A | 0 |
| Marketable Securities | 1 | 0 | 0 | 1 | 0 |
| TOTAL | $31 | $0 | $7 | $3 | $5 |
| Non-Current Assets | |||||
| PPE Net | 1 | N/A | N/A | 7 | 9 |
| TOTAL | $1 | $N/A | $N/A | $7 | $9 |
| Total Assets | $32 | $0 | $7 | $10 | $14 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 257 | 273 | 291 | 307 | 314 |
| Accrued Expenses | 916 | 745 | 672 | 749 | 709 |
| Other current liabilities | 1,214 | 1,784 | 1,345 | 976 | 793 |
| TOTAL | $2,608 | $2,961 | $2,467 | $2,305 | $2,089 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 75 | 0 | 0 | 0 | 0 |
| TOTAL | $75 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,683 | $2,961 | $2,467 | $2,305 | $2,089 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 21,418 | 20,738 | 19,929 | 18,120 | 17,945 |
| Common Shares | 16 | 14 | 13 | 12 | 10 |
| Retained earnings | -53,919 | -53,261 | -52,716 | -51,813 | -50,564 |
| Other shareholders' equity | -240 | -241 | -241 | -240 | -241 |
| TOTAL | $-2,651 | $-2,961 | $-2,459 | $-2,295 | $-2,075 |
| Total Liabilities And Equity | $32 | $1 | $7 | $10 | $14 |